Stocks / NASDAQ / MyMD Pharmaceuticals Inc.

MyMD Pharmaceuticals Inc.

Our Opinion

MyMD Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“Submitted to the FDA a four-month interim analysis of a long-term animal study of MYMD-1 to support our long-term aging and lifespan program.” Read the following article

Company Description

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical-stage small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease.

Company Website: